Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From the shareholder letter - our future

From the shareholder letter - our future

posted on Feb 07, 2008 07:57AM

2008 finds us in a better position to build a dynamic and exciting future for Patriot and it is our intent to do that. Our M&A search activity is being expanded by our having initiated efforts to engage an investment banking firm to help introduce us to candidate companies. We have already looked at a number of companies and are cautiously evaluating financial information. The range of companies we have looked at and will continue to focus on includes some in various areas of technology, [early-stage investment], companies with established business operations, and interesting business units that offer opportunity for growth and profitability.

Did any one else notice this comment? Are we considering being a Swartz type lender? Will we see more Holocom type deals?

Share
New Message
Please login to post a reply